Cephalosporin

Reading File

Finding Sources

Reading File

Loading Image

That image is the penicillin structure. The truncated Katzung reading had extensive cephalosporin data. I now have everything needed for a comprehensive answer. Let me compile it.

Cephalosporins

Cephalosporins are a large family of beta-lactam antibiotics derived from the fungus Acremonium (formerly Cephalosporium acremonium). They share the core beta-lactam ring with penicillins but have a dihydrothiazine ring instead of the thiazolidine ring, which confers greater stability against many beta-lactamases.

1. Mechanism of Action

Like all beta-lactams, cephalosporins inhibit bacterial cell wall synthesis by binding to and inactivating penicillin-binding proteins (PBPs) - the transpeptidase enzymes that cross-link the peptidoglycan strands of the cell wall. This leads to a structurally weakened wall, osmotic instability, and ultimately bactericidal cell death (in actively dividing bacteria).

Katzung's Basic and Clinical Pharmacology, 16th Ed.

2. Classification by Generation

Cephalosporins are grouped into five generations. With each successive generation, gram-negative coverage broadens and (generally) gram-positive coverage narrows.

1st Generation

Drugs: Cefazolin (IV), Cephalexin (oral), Cefadroxil (oral), Cephalothin, Cephradine, Cephapirin

Spectrum:

Excellent gram-positive coverage: streptococci, MSSA (methicillin-sensitive S. aureus), not MRSA
Limited gram-negative: E. coli, K. pneumoniae, Proteus mirabilis
Poor coverage: P. aeruginosa, Enterobacter, Serratia, Bacteroides fragilis

Key uses:

Surgical prophylaxis (cefazolin is the workhorse)
Skin and soft tissue infections
Uncomplicated UTIs (cephalexin)

Dosing (adults): Cephalexin 0.25-0.5 g q6h PO; Cefazolin 0.5-2 g q8h IV

2nd Generation

Drugs: Cefuroxime, Cefaclor, Cefoxitin, Cefotetan, Cefprozil, Loracarbef

Spectrum:

Somewhat less gram-positive than 1st generation
Better gram-negative coverage: adds H. influenzae, Moraxella catarrhalis, Neisseria spp.
Cefoxitin and cefotetan (cephamycins) have significant anaerobic coverage including B. fragilis - useful for abdominal/gynecologic infections

Key uses:

Community-acquired pneumonia, otitis media, sinusitis
Intra-abdominal infections (cefoxitin/cefotetan + metronidazole)
Surgical prophylaxis for colorectal procedures

3rd Generation

Drugs: Ceftriaxone (IV/IM), Cefotaxime (IV), Ceftazidime (IV), Cefdinir (oral), Cefixime (oral), Cefpodoxime (oral), Ceftibuten (oral)

Spectrum:

Reduced gram-positive vs. 1st generation (but still covers streptococci well)
Dramatically expanded gram-negative coverage including Enterobacterales
Ceftazidime uniquely covers P. aeruginosa among 3rd-gen agents
Excellent CSF penetration (ceftriaxone, cefotaxime) - preferred for meningitis

Key uses:

Bacterial meningitis (ceftriaxone - standard of care)
Community-acquired pneumonia (ceftriaxone)
Gonorrhea (ceftriaxone IM - first-line)
Typhoid fever, enteric fever
Septicemia, serious gram-negative infections

Ceftriaxone is particularly notable: long half-life (~8 hrs), once-daily dosing (1-2 g/day), and excellent biliary excretion.

4th Generation

Drugs: Cefepime (IV only)

Spectrum:

Extended spectrum combining good gram-positive (including Staphylococcus) AND gram-negative coverage
Active against P. aeruginosa and many Enterobacterales
More resistant to AmpC beta-lactamases than 3rd-gen agents
NOT active against MRSA, B. fragilis, or enterococci

Key uses:

Hospital-acquired pneumonia, febrile neutropenia
Pseudomonal infections where piperacillin-tazobactam is not appropriate
Empiric therapy in critically ill patients

5th Generation

Drugs: Ceftaroline (IV), Ceftobiprole (IV)

Spectrum:

Unique: active against MRSA (binds PBP2a, the altered PBP that confers methicillin resistance)
Broad gram-negative coverage similar to 3rd generation
No anti-pseudomonal activity (ceftaroline)

Key uses:

MRSA skin and soft tissue infections (ceftaroline - FDA-approved)
Community-acquired bacterial pneumonia

Siderophore Cephalosporin (Novel Class)

Drug: Cefiderocol

Uses an iron-chelating siderophore moiety to be actively transported into gram-negative bacteria via iron channels, bypassing many resistance mechanisms. Active against extensively drug-resistant (XDR) Gram-negatives including carbapenem-resistant Acinetobacter, Pseudomonas, and Enterobacterales.

Katzung's Basic and Clinical Pharmacology, 16th Ed.

Cephalosporin + Beta-Lactamase Inhibitor Combinations

Combination	Key Activity
Ceftolozane-tazobactam	MDR P. aeruginosa, ESBL Enterobacterales
Ceftazidime-avibactam	P. aeruginosa, KPC-producing Enterobacterales (Class A+C BLases; NOT MBL)

These are reserved for multidrug-resistant infections such as complicated UTIs and intra-abdominal infections.

Lippincott Illustrated Reviews: Pharmacology

3. Pharmacokinetics

Property	Detail
Distribution	Good tissue/fluid penetration; 3rd-gen penetrate CSF well
Protein binding	Variable (ceftriaxone: ~90%, cefazolin: ~85%)
Excretion	Primarily renal (glomerular filtration + tubular secretion); ceftriaxone is biliary/dual
Half-life	Most: 1-2 hrs; ceftriaxone: ~8 hrs (once-daily dosing)
Renal dosing	Required for most (except ceftriaxone) when CrCl is reduced

Probenecid blocks tubular secretion and increases serum levels significantly.

Dosing adjustments (Katzung Table 43-2 reference):

Drug	Normal Adult Dose	At CrCl ~50 mL/min	At CrCl ~10 mL/min
Cephalexin PO	0.25-0.5 g q6h	50%	25%
Cefazolin IV	0.5-2 g q8h	50%	25%

Katzung's Basic and Clinical Pharmacology, 16th Ed.

4. Adverse Effects

Effect	Details
Hypersensitivity	Rashes, urticaria, rarely anaphylaxis. Most common class adverse effect
Cross-reactivity with penicillins	~1-2% true cross-reactivity (via shared beta-lactam ring or R1 side chain). Patients with penicillin allergy can often safely receive cephalosporins with dissimilar R1 side chains
GI upset	Nausea, diarrhea, C. difficile colitis
Hypoprothrombinemia	Especially cefoperazone, cefamandole (methyltetrazolethiol side chain) - disulfiram-like reaction with alcohol
Nephrotoxicity	Rare; potentiated by aminoglycosides
Coombs positivity	Non-hemolytic; common with ceftriaxone
Biliary sludge/pseudolithiasis	Ceftriaxone (forms calcium-ceftriaxone salt in bile)
CNS toxicity	Rare seizures at very high doses or in renal failure (especially cefepime)

5. Allergy & Cross-Reactivity

Patients with cephalosporin allergy have a higher risk of reacting to other beta-lactams due to:

Shared beta-lactam ring structure
Similar R1 side chain groups

Cephalosporin-allergic patients most often tolerate other cephalosporins with different R1 side chains. True penicillin cross-reactivity is low (~1-2%), and a history of mild penicillin rash is not a contraindication to using cephalosporins in most clinical guidelines.

Red Book 2021 (AAP Committee on Infectious Diseases)

6. Quick Clinical Summary Table

Generation	Key Drugs	Gram+	Gram-	Anaerobes	Special Feature
1st	Cefazolin, Cephalexin	+++	+	-	Surgical prophylaxis
2nd	Cefuroxime, Cefoxitin	++	++	+(cephamycins)	Abdominal surgery
3rd	Ceftriaxone, Ceftazidime	+	+++	-	Meningitis, gonorrhea; Ceftazidime = Pseudomonas
4th	Cefepime	++	+++	-	Febrile neutropenia, nosocomial
5th	Ceftaroline	+++ (MRSA)	++	-	Only cephalosporin for MRSA
Novel	Cefiderocol	-	++++ (XDR)	-	Bypasses iron-channel resistance

Key memory trick: "ESKAPE" organisms guide generation selection. As generation increases, cover shifts from gram-positives (skin bugs, MSSA) to gram-negatives (hospital bugs, Pseudomonas). Only the 5th generation breaks this pattern by recapturing MRSA activity.

Sources: Katzung's Basic and Clinical Pharmacology, 16th Ed. | Lippincott Illustrated Reviews: Pharmacology | Red Book 2021 (AAP)

This is a shared conversation. Sign in to Orris to start your own chat.